中国抗体在美国完成SM17 I期临床试验首例健康受试者给药

HONG KONG, Jun 15, 2022 – (亚太商讯 via SEAPRWire.com) – 中国抗体制药有限公司(“中国抗体”或“公司”,连同其附属公司,统称“集团”;股份代号:3681.HK),专注研......

SinoMab Dosed First Healthy Subject in Phase I Clinical Trial of SM17 in the U.S.

HONG KONG, Jun 15, 2022 – (ACN Newswire via SEAPRWire.com) – SinoMab BioScience Limited (“SinoMab” or the “Company”, together with its subsidiaries, the “Group”,...

Sarawak Consolidated Industries Berhad Welcomes New Batch of Trainees for Industrial Training

KUCHING, MALAYSIA, Jun 15, 2022 – (ACN Newswire via SEAPRWire.com) – Sarawak Consolidated Industries Berhad (SCIB), a civil engineering specialist, is pleased to welcome...